通过实施与临床策略战术改善头晕治疗-2(DIZZTINCT-2)项目——一项临床试验方案
DIZZTINCT-2试验包含健康系统层面的阶梯楔形干预和嵌入式患者个体随机临床试验,旨在改善急诊科急性眩晕患者的诊疗。医生部分主要结局为循证诊疗实践的使用,患者部分主要结局为4周内头晕残障指数。
要点
- 急性眩晕评估中,DHT、CRM和GSE等高效措施常使用不足,而神经影像常过度使用。
- 试验采用阶梯楔形设计在急诊科实施医生层面干预,并同时随机患者接受干预或标准出院材料。
- 医生部分主要结局为索引急诊就诊期间循证诊疗实践的使用;患者部分为4周头晕残障指数。
核心结论
- DIZZTINCT-2试验针对如何改善急诊科急性眩晕患者诊疗中的关键不确定性,并填补患者改善程度与速度的随访数据缺口。
研究设计与样本
- 试验包含健康系统层面的阶梯楔形干预和嵌入式患者个体随机临床试验,先进行6个月干预期前阶段,随后在参与的急诊科以11个波次交错实施干预,之后约6个月干预期后阶段。
- 患者在每個急诊科医生层面干预实施前后招募,完成基线调查后按性别、年龄和医疗中心分层,通过中央计算机随机化分配至干预组或对照组患者材料。
关键数值与推荐
- 医生部分主要结局为索引急诊就诊期间循证诊疗实践的使用。
- 患者部分主要结局为4周内的头晕残障指数。
- 干预组患者收到干预材料,对照组患者收到医院标准出院后材料。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The evaluation and management of acute vertigo presentations is challenging for both patients and physicians. Benign paroxysmal positional vertigo (BPPV), acute unilateral vestibulopathy (e.g., vestibular neuritis), and stroke are priority diagnostic considerations in this circumstance. Existing evidence can be used to guide the diagnosis and treatment, however high value care opportunities-such as the Dix-Hallpike test (DHT), canalith repositioning maneuver (CRM), and gaze stabilization exercises (GSE)-are often underused, while neuroimaging studies are often overused. METHODS: This trial contains a health system focused stepped wedge intervention and an embedded individually patient randomized clinical trial. The study will start with a 6-month pre-intervention period. This will be followed by staggered intervention at the engaged EDs in 11 waves and then an approximately 6-month post-intervention period. Concurrently, patients will be recruited before and after the physician level intervention is implemented at each ED. Enrolled participants will complete baseline survey and then be randomized individually, stratified by sex, age, and medical center, to the intervention or control arm patient materials using central computerized randomization. The intervention arm will be sent intervention materials and the control arm will be sent the hospital's standard post-discharge materials. The primary outcome of the physician-based part of the trial is use of evidence-based care practices during the index ED visit. The primary outcome of the patient focused part of the trial is the dizziness handicap index over 4 weeks. DISCUSSION: The DIZZTINCT-2 trial addresses key areas of uncertainty in how to improve the care of emergency department patients with acute vertigo. In addition, follow up data on how much and how fast patients improved was needed. DIZZTINCT-2 will address these key knowledge gaps efficiently. TRIAL REGISTRATION: Clinicaltrials.gov NCT05634902. Registered on November 2022.
引用
- Meurer WJ, Park S, Nguyen H, et al. DIZZiness treatment through implementation and clinical strategy Tactics-2 (DIZZTINCT-2) project-a clinical trial protocol. Trials. 2025. PMID: 41024017. doi:10.1186/s13063-025-09055-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。